James Davis, MD
Internal Medicine · Madison, WINPI 1326006974
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,644 of the $22,920 with a category attached, or 98.8%. 5 manufacturers reported payments, led by Currax Pharmaceuticals LLC at 51.3% of the total. Among internal medicine clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 12 payments — averaging $1909.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Currax Pharmaceuticals LLC$12K
- Axsome Therapeutics, Inc.$11K
- Taiho Oncology, Inc.$155
- AstraZeneca$95
- Pfizer$26
Across 6 payments — averaging $46,636 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$280K
What the payments were for
- Consulting fees$22,64499%
- Speaking & faculty fees$1671%
- Travel & lodging$830%
- Food & beverage$260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Currax Pharmaceuticals LLC | 3 | $11,750 |
| Axsome Therapeutics, Inc. | 3 | $10,894 |
| Taiho Oncology, Inc. | 3 | $155 |
| AstraZeneca | 2 | $95 |
| Pfizer | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CONTRAVE$3,250
How this compares
$22,920 in reported general payments places this provider in the 95th percentile of 1,411 internal medicine providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Varenicline Tartrate | 92 | $26,179 |
| Bupropion Hcl SrBupropion Hcl | 13 | $230 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Madison
- Andrew NickelMadison$32K
- Amit ChitnisMadison$11K
- Kenneth CogginsMadison$10K
- Karyn BaumMadison$4K
- Jeremiah DeptaMilwaukee$723K
- James KuplicSheboygan$201K
- Erik StilpMilwaukee$116K
- Christopher WeberGermantown$113K
- Alejandro EismaWinnebago$84K
- Hammam ShereefMilwaukee$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.